Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR1 | P21554 | 3/20 | 0.43 |
| ▸ | TACR1 | P25103 | 1/20 | 0.41 |
| ▸ | PTGS1 | P23219 | 3/20 | 0.38 |
| ▸ | PTGS2 | P35354 | 3/20 | 0.38 |
| ▸ | MGLL | Q99685 | 2/20 | 0.38 |
| ▸ | FAAH | O00519 | 2/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.38 |
| ▸ | LMNA | P02545 | 3/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | NPC1 | O15118 | 1/20 | 0.35 |
| ▸ | RAB9A | P51151 | 1/20 | 0.35 |
| ▸ | GAA | P10253 | 1/20 | 0.34 |
| ▸ | HTT | P42858 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6728550 | 1.00 | CNR1 (0.43) | CNR1TACR1PTGS1PTGS2MGLL | |
| SCHEMBL14519637 | 0.87 | CNR1 (0.45) | CNR1TACR1PTGS1PTGS2MGLL | |
| SCHEMBL10124670 | 0.87 | CNR1 (0.39) | CNR1TACR1ALDH1A1SMN1; SMN2LMNA | |
| SCHEMBL11091144 | 0.84 | CNR1 (0.49) | CNR1TACR1PTGS1PTGS2MGLL | |
| SCHEMBL11484816 | 0.83 | CNR1 (0.48) | CNR1TACR1PTGS1PTGS2MGLL | |
| SCHEMBL7699126 | 0.83 | CNR1 (0.48) | CNR1TACR1PTGS1PTGS2MGLL | |
| SCHEMBL11488928 | 0.83 | CNR1 (0.48) | CNR1TACR1PTGS1PTGS2MGLL | |
| SCHEMBL11490607 | 0.82 | CNR1 (0.47) | CNR1TACR1PTGS1PTGS2MGLL | |
| SCHEMBL7511083 | 0.82 | CNR1 (0.47) | CNR1TACR1PTGS1PTGS2MGLL | |
| SCHEMBL11476370 | 0.82 | CNR1 (0.47) | CNR1TACR1PTGS1PTGS2MGLL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6677451-B2 | POLYMER STABILIZERS; OXYGEN, HEAT, RADIATION RESISTANCES; DISCOLORATION INHIBITION; COATINGS; FIBERS; TAPES; FILMS; PAPERMAKING; HALS; FIREPROOFING; OXIDATION OF A 1-ALLYL-SUBSTITUTED STERICALLY HINDERED AMINE | CIBA SPECIALTY CHEMICALS CORPORATION | 2004-01-13 | — | — | US | disclosed |
| US-20020094976-A1 | Preparation of sterically hindered amine ethers | ZEDDA ALESSANDRO (IT) | 2002-07-18 | — | — | US | disclosed |
| US-6420462-B1 | OXIDATION RESISTANCE, HEAT RESISTANT AND ACTINIC DEGRADATIONHETEROCYCLIC AMINE OXIDES | CIBA SPECIALTY CHEMICALS CORPORATION | 2002-07-16 | — | — | US | disclosed |
| US-6117995-A | OXIDATION OF THE CORRESPONDING HETEROCYCLIC AMINE COMPOUND | CIBA SPECIALTY CHEMICALS CORPORATION (US) | 2000-09-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020094976-A1 | Preparation of sterically hindered amine ethers | CBR1, CBR3, RER1 | CNR1 144/4885TACR1 3229/4885PTGS1 2395/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.